Low-concentration, continuous brachial plexus block in the management of Purple Glove Syndrome: A case report

被引：0

作者：

Singh G. ^{[1
]}

Cherian V.T. ^{[1
]}

Thomas B.P. ^{[2
]}

机构：

[1] Department of Anaesthesiology, Christian Medical College, Vellore 632 004, Tamil Nadu

[2] Dr Paul Brand Centre for Hand Surgery, Christian Medical College, Vellore 632 004, Tamil Nadu

来源：

Journal of Medical Case Reports | / 4卷 / 1期

关键词：

Fentanyl; Bupivacaine; Brachial Plexus; Ropivacaine; Stellate Ganglion;

D O I：

10.1186/1752-1947-4-48

中图分类号：

学科分类号：

摘要：

Introduction. Purple Glove Syndrome is a devastating complication of intravenous phenytoin administration. Adequate analgesia and preservation of limb movement for physiotherapy are the two essential components of management. Case presentation. A 26-year-old Tamil woman from India developed Purple Glove Syndrome after intravenous administration of phenytoin. She was managed conservatively by limb elevation, physiotherapy and oral antibiotics. A 20G intravenous cannula was inserted into the sheath of her brachial plexus and a continuous infusion of bupivacaine at a low concentration (0.1%) with fentanyl (2 g/ml) at a rate of 1 to 2 ml/hr was given. She had adequate analgesia with preserved motor function which helped in physiotherapy and functional recovery of the hand in a month. Conclusion. A continuous blockade of the brachial plexus with a low concentration of bupivacaine and fentanyl helps to alleviate the vasospasm and the pain while preserving the motor function for the patient to perform active movements of the finger and hand. © 2010 Singh et al; licensee BioMed Central Ltd.

引用

共 18 条

[1]

Snelson C., Dieckman B., Recognizing and managing purple glove syndrome, Crit Care Nurse, 20, 3, pp. 54-61, (2000)

[2]

Bhattacharjee P., Glusac E.J., Early histopathologic changes in purple glove syndrome, J Cutan Pathol, 31, 7, pp. 513-515, (2004)

[3]

Edwards J.J., Bosek V., Extravasation injury of the upper extremity by intravenous phenytoin, Anesth Analg, 94, 3, pp. 672-673, (2002)

[4]

O'Brien T.J., Cascino G.D., So E.L., Hanna D.R., Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin, Neurology, 51, 4, pp. 1034-1039, (1998)

[5]

Righini M., Angellillo-Scherrer A., Gueddi S., Le Gal G., Bounameaux H., Management of severe ischemia of the hand following intra-arterial injection, Thromb Haemost, 94, 1, pp. 219-221, (2005)

[6]

Yoshikawa H., Abe T., Oda Y., Purple glove syndrome caused by oral administration of phenytoin, J Child Neurol, 15, 11, (2000)

[7]

Burneo J.G., Anandan J.V., Barkley G.L., A prospective study of the incidence of the purple glove syndrome, Epilepsia, 42, 9, pp. 1156-1159, (2001)

[8]

Spengler R.F., Arrowsmith J.B., Kilarski D.J., Buchanan C., Von Behren L., Graham D.R., Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors, Arch Intern Med, 148, 6, pp. 1329-1333, (1988)

[9]

British National Formulary, (1999)

[10]

Breivik H., Cousins M.J., Lofstrom J.B., Sympathetic neural blockade of upper and lower extremity, Neural Blockade in Clinical Anesthesia and Management of Pain, pp. 411-445, (1998)

← 1 2 →